Latest news
FDA Grants RMAT Designation to Sasineprocel for Parkinson Disease - neurologylive.comneurologylive.com · Tue, 04 Aug 2026 22:35:24 GMTAspen Neuroscience Receives RMAT Designation for Parkinson's Therapy - SynBioBetaSynBioBeta · Tue, 04 Aug 2026 00:00:00 GMTFDA backs faster development path for Parkinson’s cell therapy - Parkinson's News TodayParkinson's News Today · Mon, 03 Aug 2026 22:15:42 GMTClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel - ACCESS NewswireACCESS Newswire · Fri, 31 Jul 2026 20:07:34 GMTAspen's Parkinson's Cell Therapy Gets FDA RMAT Designation—Not Approval - Stock TitanStock Titan · Fri, 31 Jul 2026 20:05:00 GMTFDA grants Aspen RMAT designation for cell therapy in Parkinson's disease - allsci.comallsci.com · Fri, 31 Jul 2026 12:19:16 GMTAspen Neuroscience Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel (ANPD001) to Treat Parkinson's Disease - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMTAspen Neuroscience Gains Key FDA Designation for Parkinson’s Cell Therapy - TipRanksTipRanks · Thu, 30 Jul 2026 07:00:00 GMT